Ignite Creation Date:
2025-12-24 @ 12:58 PM
Ignite Modification Date:
2025-12-27 @ 10:17 PM
Study NCT ID:
NCT01943461
Status:
COMPLETED
Last Update Posted:
2020-09-30
First Post:
2013-09-06
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor JPN)
Sponsor:
Merck KGaA, Darmstadt, Germany
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-09-02
Start Date Type:
ACTUAL
Primary Completion Date:
2015-01-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-09-25
Completion Date Type:
ACTUAL
First Submit Date:
2013-09-06
First Submit QC Date:
None
Study First Post Date:
2013-09-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-09-03
Results First Submit QC Date:
None
Results First Post Date:
2020-09-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-09-29
Last Update Post Date:
2020-09-30
Last Update Post Date Type:
ACTUAL